Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIxSCAN is a medical technology company specializing in artificial intelligence-driven diagnostic imaging solutions. The company develops advanced deep learning algorithms to analyze medical images, such as CT scans, for the early detection and characterization of thoracic diseases, including lung cancer and pulmonary nodules. AIxSCAN's platform is designed to integrate seamlessly into clinical workflows, providing radiologists with automated tools to improve diagnostic precision and efficiency. By focusing on early-stage detection, the company aims to significantly improve patient outcomes and streamline the screening process for high-risk populations. Their technology is particularly focused on reducing false positives in low-dose CT lung cancer screenings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIxSCAN.